Cassava Sciences Inc. (SAVA)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
24 Aug 2023 |
ROBERTSON SANFORD |
Director |
23 Aug 2023 |
30,000 |
17.45 |
523,500 |
23 Aug 2023 |
BARRY RICHARD |
Director |
22 Aug 2023 |
16,571 |
16.65 |
275,907 |
23 Aug 2023 |
BARRY RICHARD |
Director |
21 Aug 2023 |
1,906 |
16.80 |
32,021 |
08 Mar 2023 |
BARRY RICHARD |
Director |
07 Mar 2023 |
77,276 |
25.76 |
1,990,630 |
08 Mar 2023 |
BARRY RICHARD |
Director |
06 Mar 2023 |
11,565 |
26.13 |
302,193 |
25 Aug 2022 |
BARRY RICHARD |
Director |
23 Aug 2022 |
36,159 |
23.79 |
860,223 |
24 Aug 2022 |
KUPIEC JAMES WILLIAM |
Chief Clinical Dev. Officer |
23 Aug 2022 |
2,500 |
24.44 |
61,100 |
16 Aug 2022 |
SCHOEN ERIC |
Chief Financial Officer |
12 Aug 2022 |
2,500 |
19.95 |
49,875 |
16 Aug 2022 |
ROBERTSON SANFORD |
Director |
12 Aug 2022 |
100,000 |
20.69 |
2,069,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock